Indraprastha Medical

Jump to

Indraprastha Medical can move to Rs 50: SP Tulsian

Indraprastha Medical can move to Rs 50 in next twelve months, says SP Tulsian, sptulsian.com.
Find out: Tater picks 2 hot buys for your portfolio

Backed on pure business model, Aashish Tater, head of research at Fort Share Broking picks Arshiya International and Indraprasth Medical. He recommends a buy on dips from a long term perspective, for both stocks, looking forward at the potential of the innovative business structure.
Indraprastha Medical Q4 PAT up 29% at Rs 9 cr

Indraprastha Medical has announced its fourth quarter results. The company’s Q4 FY11 standalone revenue was up 18% at Rs 121 crore versus Rs 103 crore, year-on-year, YoY.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Indraprastha Medical

Indraprastha Medical can move to Rs 50: SP Tulsian

Find out: Tater picks 2 hot buys for your portfolio

Indraprastha Medical Q4 PAT up 29% at Rs 9 cr